Skip to main content

Table 1 Differentially expressed miRNAs using HTG EdgeSeq miRNA Whole Transcriptome Assay for HCC1937 Parental vs OlaR1 cell line

From: MiR-181a targets STING to drive PARP inhibitor resistance in BRCA- mutated triple-negative breast cancer and ovarian cancer

Probe

Parental (mean normalized)

OlaR (mean normalized)

FC2

Adj. p-value

miR-16-5p

5760

12156

2.09

8.39E-06

let-7f-5p

4044

7922

1.94

4.04E-05

miR-25-3p

1070

2091

1.93

1.00E-03

miR-181a-5p

2707

5193

1.90

1.83E-04

miR-21-5p

20160

38679

1.90

9.10E-05

miR-151a-3p

1006

1836

1.81

2.00E-03

miR-107

3335

5831

1.73

1.30E-03

miR-29a-3p

6243

10896

1.73

4.10E-03

miR-106b-5p

1631

2784

1.69

1.53E-02

miR-93-5p

2204

3728

1.68

2.50E-03

miR-103a-3p

3979

6674

1.67

2.60E-03

miR-191-5p

1818

3013

1.65

5.42E-04

miR-22-3p

4394

7262

1.64

1.28E-02

miR-29b-3p

8474

13981

1.64

3.70E-03

let-7d-5p

4211

6891

1.62

6.80E-03

miR-30b-5p

2580

4173

1.61

3.50E-03

miR-200c-3p

6711

10725

1.59

1.23E-02

miR-31-5p

9861

15412

1.55

2.90E-02

miR-99b-5p

1245

1929

1.54

9.70E-03

let-7i-5p

1781

2711

1.51

2.18E-02

miR-2861

5604

3681

− 1.51

9.70E-03

miR-5585-3p

2666

1710

− 1.55

1.93E-02

miR-6780b-5p

1745

1112

− 1.56

7.39E-05

miR-6088

3439

2132

− 1.61

1.02E-05

miR-6126

9182

5629

− 1.62

1.07E-04

miR-6803-5p

2051

1241

− 1.64

9.73E-04

miR-3687

6336

1622

− 3.88

2.62E-60

  1. 1OlaR Olaparib- resistant, 2FC fold changeÂ